Education
About Us
Working with TipRanks
Follow Us
Dexcom (DXCM)
NASDAQ:DXCM
Total Valuation
Dexcom has a market cap or net worth of $23.86B. The enterprise value is $26.67B.
Market Cap$23.86B
Enterprise Value$26.67B
Share Statistics
Dexcom has 390,016,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding390,016,270
Owned by Insiders0.47%
Owned by Institutions0.57%
Financial Efficiency
Dexcom’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 10.20%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)10.20%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee395.39K
Profits Per Employee56.49K
Employee Count10,200
Asset Turnover0.62
Inventory Turnover2.94
Valuation Ratios
The current PE Ratio of Dexcom is 34.1. Dexcom’s PEG ratio is 39.32.
PE Ratio34.1
PS Ratio7.80
PB Ratio14.97
Price to Fair Value14.97
Price to FCF49.89
Price to Operating Cash Flow16.47
PEG Ratio39.32
Income Statement
In the last 12 months, Dexcom had revenue of 4.03B and earned 576.20M in profits. Earnings per share was 1.46.
Revenue4.03B
Gross Profit2.44B
Operating Income600.00M
Pretax Income709.00M
Net Income576.20M
EBITDA945.70M
Earnings Per Share (EPS)1.46
Cash Flow
In the last 12 months, operating cash flow was 1.45B and capital expenditures -386.20M, giving a free cash flow of 1.06B billion.
Operating Cash Flow1.45B
Free Cash Flow1.06B
Free Cash Flow per Share2.72
Dividends & Yields
Dexcom pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.20
52-Week Price Change-10.83%
50-Day Moving Average70.34
200-Day Moving Average78.02
Relative Strength Index (RSI)34.76
Average Volume (3m)5.88M
Important Dates
Dexcom upcoming earnings date is Feb 5, 2026, After Close (Confirmed).
Last Earnings DateOct 30, 2025
Next Earnings DateFeb 5, 2026
Ex-Dividend Date―
Financial Position
Dexcom as a current ratio of 1.47, with Debt / Equity ratio of 92.48%
Current Ratio1.47
Quick Ratio1.28
Debt to Market Cap0.08
Net Debt to EBITDA2.10
Interest Coverage Ratio31.58
Taxes
In the past 12 months, Dexcom has paid 132.80M in taxes.
Income Tax132.80M
Effective Tax Rate0.19
Enterprise Valuation
Dexcom EV to EBITDA ratio is 35.37, with an EV/FCF ratio of 53.03.
EV to Sales8.29
EV to EBITDA35.37
EV to Free Cash Flow53.03
EV to Operating Cash Flow33.80
Balance Sheet
Dexcom has $3.32B in cash and marketable securities with $2.52B in debt, giving a net cash position of $801.10M billion.
Cash & Marketable Securities$3.32B
Total Debt$2.52B
Net Cash$801.10M
Net Cash Per Share$2.05
Tangible Book Value Per Share$4.88
Margins
Gross margin is 59.01%, with operating margin of 14.88%, and net profit margin of 14.29%.
Gross Margin59.01%
Operating Margin14.88%
Pretax Margin17.58%
Net Profit Margin14.29%
EBITDA Margin23.45%
EBIT Margin18.05%
Analyst Forecast
The average price target for Dexcom is $88.58, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$88.58
Price Target Upside44.79% Upside
Analyst ConsensusStrong Buy
Analyst Count21
Revenue Growth Forecast14.21%
EPS Growth Forecast5.66%